Medication Strength Change: Deferasirox

posted Nov 12, 2019, 6:35 PM by Muhammad Fikree Ahmad   [ updated Nov 12, 2019, 6:36 PM ]
6 November 2019 (Circular No. SP PPUM: 460/2019)

Please be informed that Novartis Corporation (Malaysia) Sdn. Bhd. has ceased the production of Deferasirox 500mg Dispersible Tablet (Exjade) and replaced the product to Deferasirox 360mg Film-Coated Tablet (Exjade).




Product Name

:

Exjade

Active Ingredient

:

Deferasirox

Strength

:

360mg

Dosage Form

:

Tablet

Product Registration Number

:

MAL18016071ARZ

Manufacturer

:

Novartis

Formulary Category

:

Special Formulary

Prescriber

:

Haematologist